These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 15932647)

  • 1. Is complementary and alternative medicine (CAM) cost-effective? A systematic review.
    Herman PM; Craig BM; Caspi O
    BMC Complement Altern Med; 2005 Jun; 5():11. PubMed ID: 15932647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Square pegs and round holes? A review of economic evaluation in complementary and alternative medicine.
    Hulme C; Long AF
    J Altern Complement Med; 2005 Feb; 11(1):179-88. PubMed ID: 15750380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.
    Bereza BG; Machado M; Einarson TR
    Clin Ther; 2009 Jun; 31(6):1279-308. PubMed ID: 19695395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of economic methods used in complementary medicine.
    Doran CM; Chang DH; Kiat H; Bensoussan A
    J Altern Complement Med; 2010 May; 16(5):591-5. PubMed ID: 20804369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing appropriate measures of the benefits of complementary and alternative medicine.
    Meenan R
    J Health Serv Res Policy; 2001 Jan; 6(1):38-43. PubMed ID: 11219359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Evaluation of Complementary and Alternative Medicine in Oncology: Is There a Difference Compared to Conventional Medicine?
    Huebner J; Prott FJ; Muecke R; Stoll C; Buentzel J; Muenstedt K; Micke O;
    Med Princ Pract; 2017; 26(1):41-49. PubMed ID: 27607437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health economic evaluation in complementary medicine: development within the last decades concerning local origin and quality.
    Ostermann T; Krummenauer F; Heusser P; Boehm K
    Complement Ther Med; 2011 Dec; 19(6):289-302. PubMed ID: 22036521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial.
    Klafke N; Mahler C; von Hagens C; Rochon J; Schneeweiss A; Müller A; Salize HJ; Joos S
    Trials; 2015 Feb; 16():51. PubMed ID: 25887713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review.
    Bardia A; Barton DL; Prokop LJ; Bauer BA; Moynihan TJ
    J Clin Oncol; 2006 Dec; 24(34):5457-64. PubMed ID: 17135649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic analysis of complementary medicine: a systematic review.
    White AR; Ernst E
    Complement Ther Med; 2000 Jun; 8(2):111-8. PubMed ID: 10859604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations.
    Herman PM; Poindexter BL; Witt CM; Eisenberg DM
    BMJ Open; 2012; 2(5):. PubMed ID: 22945962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and alternative medicine costs - a systematic literature review.
    Maxion-Bergemann S; Wolf M; Bornhöft G; Matthiessen PF; Wolf U
    Forsch Komplementmed; 2006; 13 Suppl 2():42-5. PubMed ID: 16883079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing efficiency: economic evaluation and the agenda for CAM researchers.
    Andrews GJ
    Complement Ther Clin Pract; 2005 Nov; 11(4):253-61. PubMed ID: 16290896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO.
    van Tilburg MA; Palsson OS; Levy RL; Feld AD; Turner MJ; Drossman DA; Whitehead WE
    BMC Complement Altern Med; 2008 Jul; 8():46. PubMed ID: 18652682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes.
    Quattropani C; Ausfeld B; Straumann A; Heer P; Seibold F
    Scand J Gastroenterol; 2003 Mar; 38(3):277-82. PubMed ID: 12737442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration and reimbursement of complementary and alternative medicine by managed care and insurance providers: 2000 update and cohort analysis.
    Pelletier KR; Astin JA
    Altern Ther Health Med; 2002; 8(1):38-9, 42, 44 passim. PubMed ID: 11795621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of complementary medicine by adult patients participating in cancer clinical trials.
    Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
    Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of complementary alternative medicine for asthma and allergy in Europe and Germany.
    Schäfer T
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2 Suppl 1):S5-10. PubMed ID: 15330007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insurance coverage and subsequent utilization of complementary and alternative medicine providers.
    Lafferty WE; Tyree PT; Bellas AS; Watts CA; Lind BK; Sherman KJ; Cherkin DC; Grembowski DE
    Am J Manag Care; 2006 Jul; 12(7):397-404. PubMed ID: 16834526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.